B of A Securities Maintains Buy on CVS Health, Lowers Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
B of A Securities analyst Michael Cherny has maintained a Buy rating on CVS Health (NYSE:CVS) but lowered the price target from $95 to $77.

May 02, 2024 | 4:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
B of A Securities maintains a Buy rating on CVS Health but lowers the price target from $95 to $77.
While the maintenance of a Buy rating suggests continued confidence in CVS Health's fundamentals and potential for growth, the reduction in the price target could reflect adjustments in market conditions, valuation concerns, or revised earnings expectations. This mixed signal might lead to short-term uncertainty among investors, potentially impacting the stock's price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100